Form 8-K - Current report:
SEC Accession No. 0001104659-25-046845
Filing Date
2025-05-09
Accepted
2025-05-09 17:20:51
Documents
16
Period of Report
2025-05-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2514418d1_8k.htm   iXBRL 8-K 32971
2 EXHIBIT 5.1 tm2514418d1_ex5-1.htm EX-5.1 13632
3 EXHIBIT 10.1 tm2514418d1_ex10-1.htm EX-10.1 252902
7 GRAPHIC tm2514418d1_ex5-1img01.jpg GRAPHIC 3551
  Complete submission text file 0001104659-25-046845.txt   552582

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nvct-20250509.xsd EX-101.SCH 3014
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvct-20250509_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvct-20250509_pre.xml EX-101.PRE 22358
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2514418d1_8k_htm.xml XML 3652
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Filer) CIK: 0001875558 (see all company filings)

EIN.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41264 | Film No.: 25931747
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)